-transparent.png){kind=logo}
In a 37 year old renal transplant woman haemolytic anaemia was observed in the course of a combined azathioprine-allopurinol therapy. Azathioprine is converted to 6-mercaptopurine, which then catalyzed by xanthine oxidase is oxidized to 6-thiouric acid. When allopurinol and azathioprine are administered simultaneously, high 6-mercaptopurine concentrations in plasma may be expected because of inhibition of xanthine oxidase activity by allopurinol. We assume that elevated plasma 6-mercaptopurine concentration could possibly be responsible for haemolytic anaemia in this renal transplant patient.
Related Publications
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
March 1974,
Annals of internal medicine,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
April 1991,
Journal of internal medicine,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
May 1993,
Journal of internal medicine,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
June 1996,
Transplantation,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
July 1990,
Journal of internal medicine,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
April 2010,
Journal of gastroenterology and hepatology,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
November 1985,
Der Internist,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
March 1981,
International journal of clinical pharmacology, therapy, and toxicology,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
January 1977,
Die Medizinische Welt,
J Zazgornik, and
K Hruby, and
P Schmidt, and
H Kopsa, and
P Pils
January 1982,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
